Tuesday, December 2, 2025 12/2/2025

The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells

Award Number: R01AI143897
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/09/2020
PERIOD OF PERFORMANCE END DATE: 11/30/2029

Group Awards By:

View Award Description

The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells - PROJECT SUMMARY Background: VDJ recombination, Class switch recombination (CSR) and somatic hypermutation (SHM) are three B lymphocyte specific processes that mediate antibody gene diversification. VDJ recombination requires the DNA double strand generation by the Recombination activation genes (RAG1 and RAG2) whereas CSR and SHM requires the single-strand DNA break activity of the Activation Induced Deaminase (AID) enzyme. Both RAG1/2 and AID activities are coupled with noncoding RNA transcription at sites of DNA break/mutation. The properties of the ncRNAs generated at sites of programmed DNA breaks are poorly characterized in B cells. Recently, advances in biology have provided compelling evidence that post-transcriptional and co-transcriptional modification of ncRNAs determine a component of RNA epigenomics and have significant role in driving cellular development and function. In this application, supported by published study (Nair et al,2021; PMID: preliminary data generated in our laboratory, we are evaluating the role of RNA modification N6-methyladenosine (m6A) and its associated enzymes METTL3 and METTL14 in B cell development, function and genomic integrity. Objective/Hypothesis: In his proposal, we will determine how RNA methylation m6A on transcripts generated in the IgH locus and the rest of the B cell genome controls programmed DNA recombination, antibody gene diversification and prevents chromosomal instability. Specific aims: Aim 1: Does m6A reader protein YTHDC1 drive CSR and SHM? Aim 2: What is the mechanism of function of m6A modification and YTHDC1 in promoting IgH diversity and preventing genomic instability in B cells? Study Design: Using cell lines and mouse models, we will establish that along with m6A writers (shown previously), the m6A reader YTHDC1 protein is important for class switch recombination and somatic hypermutation. Thereafter, using a combination of genome and RNA editing toolbox generated with CRISPR/Cas9 technology, we will evaluate the effect of RNA methylation and YTHDC1 protein to induce CSR. A RNA recognition motif of YTHDC, which is necessary for efficient CSR, will be evaluated for properties that drive CSR. Whether YTHDC1 promotes RNA dependent granule formation for promoting CSR (or SHM) will be evaluated using STORM microscopy. A cell-based assay system to evaluate SHM has been developed, the role of YTHDC1 and other m6A related proteins will be evaluated for SHM efficiency. Disease Relevance: B cells are a central component of the adaptive immune response, but also prone to undergo leukemias and lymphomas when antibody gene diversification processes are not well controlled. Proposed studies leads to a better understanding of the mechanism of antibody gene diversification but also educate us how B cell cancer (specially in context of DLBCL and Multiple Myeloma) are prevented.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $615,378 )
2026	2026	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	000	6	11/26/2025	NON-COMPETING CONTINUATION	$615,378
														Subtotal = $615,378

Issue Date FY: 2025 ( Subtotal = $596,917 )
2025	2025	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	002	5	12/4/2024	COMPETING CONTINUATION	$596,917
2025	2023	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	001	4	11/25/2024	SUPPLEMENT FOR EXPANSION	$0
2025	2023	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	003	4	5/1/2025	NON-COMPETING CONTINUATION	$0
2025	2023	THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	000	4	11/25/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $596,917

Issue Date FY: 2023 ( Subtotal = $560,085 )
2023	2023	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	000	4	8/2/2023	NON-COMPETING CONTINUATION	$507,006
2023	2023	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	001	4	8/4/2023	SUPPLEMENT FOR EXPANSION	$53,079
														Subtotal = $560,085

Issue Date FY: 2022 ( Subtotal = $632,726 )
2022	2022	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	001	3	8/12/2022	NON-COMPETING CONTINUATION	$509,471
2022	2022	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	000	2	5/18/2022	SUPPLEMENT FOR EXPANSION	$35,060
2022	2022	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	002	3	8/17/2022	SUPPLEMENT FOR EXPANSION	$88,195
														Subtotal = $632,726

Issue Date FY: 2021 ( Subtotal = $511,864 )
2021	2021	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	000	2	8/4/2021	NON-COMPETING CONTINUATION	$511,864
														Subtotal = $511,864

Issue Date FY: 2020 ( Subtotal = $514,190 )
2020	2020	TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK, THE	630 W 168TH ST FL 4	NEW YORK	NY	10032	NEW YORK	USA	Allergy and Infectious Diseases Research	000	1	9/9/2020	NEW	$514,190
														Subtotal = $514,190

Grand Total All Awards = $3,431,160

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells

Award Number: R01AI143897

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/09/2020

PERIOD OF PERFORMANCE END DATE: 11/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer